Literature DB >> 18481061

The specific case of radiopharmaceuticals and GMP--activities of the Radiopharmacy Committee.

C Decristoforo, P Elsinga, A Faivre-Chauvet, B Farstad, G Meyer, R Mikolajczak, I Penuelas, P Unak, G Westera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18481061     DOI： 10.1007/s00259-008-0827-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  1 in total

1.  GMP--three letters with many interpretations. Protection of patients or killing the clinical and research applications of PET?

Authors:  Bengt Långström; Per Hartvig
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04       Impact factor: 9.236
  1 in total
  1 in total

1.  Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals.

Authors:  C Decristoforo; I Penuelas; P Elsinga; J Ballinger; A D Winhorst; A Verbruggen; F Verzijlbergen; A Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.